Waystar Holding Corp. (WAY) Covered Calls
Waystar Holding Corp. is a leading provider of healthcare payment software, offering a cloud-native platform that simplifies the revenue cycle for medical providers. The company utilizes advanced AI and machine learning to automate financial clearance, claim management, and denial prevention. By unifying clinical, administrative, and financial data, Waystar helps healthcare organizations reduce labor costs, increase reimbursement accuracy, and improve the overall patient financial experience.
You can sell covered calls on Waystar Holding Corp. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for WAY (prices last updated Tue 12:40 PM ET):
| Waystar Holding Corp. (WAY) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 25.56 | -0.32 | 25.54 | 25.57 | 592K | 42 | 5.0 |
| Covered Calls For Waystar Holding Corp. (WAY) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| Mar 20 | 25 | 1.15 | 24.42 | 2.4% | 79.6% | |
| Apr 17 | 25 | 1.80 | 23.77 | 5.2% | 48.7% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Waystar Holding Corp. (WAY) is a premier healthcare technology firm providing mission-critical revenue cycle management (RCM) solutions. Headquartered in Lehi, Utah, and Louisville, Kentucky, the company serves over 30,000 clients, including prominent health systems and over one million distinct providers. Its business model centers on a cloud-based Software-as-a-Service (SaaS) platform that automates the complex journey of a healthcare claim—from pre-service eligibility verification to post-service payment reconciliation. By processing over 7.5 billion transactions annually, Waystar leverages a massive data network covering approximately 60% of U.S. patients.
The company’s technological backbone is its AltitudeAI engine, which utilizes a decade of transaction data to drive predictive analytics. In early 2026, Waystar reached a major milestone by introducing "Agentic AI" capabilities. This next-generation autonomous system does not just identify errors; it actively interacts within workflows to pre-populate clinical appeals and automatically correct coding discrepancies. These advancements are designed to combat the industry-wide rise in claim denials and alleviate administrative burnout by reducing manual workloads by approximately 40% for hospital staff.
Competitive Landscape
The competitive landscape for Waystar consists of legacy RCM providers and modern health-fintech firms. Primary rivals that are publicly traded on the NYSE or NASDAQ and offer active options markets include Doximity, Inc. and Phreesia, Inc.. These companies compete for market share in the digital transformation of provider-patient and provider-payer interactions.
Other notable competitors in the healthcare information services and diversified technology sectors with active options trading include CVS Health Corporation (via its Signify and provider-services units) and Alphabet Inc. (competing via Google Health analytics). Waystar distinguishes itself through its independent, "payer-agnostic" stance and its recent high-profile acquisition of Iodine Software, which integrated deep clinical data into its financial models. This combination of clinical and financial intelligence creates a significant moat against traditional billing services that lack deep clinical context.
Strategic Outlook
Strategic innovation is currently focused on achieving a "fully autonomous revenue cycle" where the majority of administrative tasks are handled by AI agents. By early 2026, the company has targeted a 17% revenue growth rate, supported by its successful integration of clinical data assets. Management is prioritizing the expansion of its platform into the mid-market and ambulatory segments, aiming to replicate the success it has seen with large enterprise health systems. These efforts are expected to drive higher net revenue retention and increase the adoption of high-margin AI modules.
The outlook involves a disciplined approach to capital allocation, with a focus on deleveraging the balance sheet following its 2024 IPO and subsequent acquisitions. In February 2026, the company reiterated its commitment to expanding adjusted EBITDA margins toward the 42% range by realizing cost synergies and leveraging its "build-once, deploy-many" SaaS architecture. By maintaining a 99% clean claim rate for its clients and continuing to lead independent satisfaction surveys, Waystar aims to solidify its position as the indispensable operating system for the modern healthcare economy.
| Top 10 Open Interest For Mar 20 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | QQQ covered calls | 1. | CTMX covered calls | |
| 2. | SLV covered calls | 7. | EWZ covered calls | 2. | PATH covered calls | |
| 3. | EEM covered calls | 8. | FXI covered calls | 3. | FLY covered calls | |
| 4. | SPY covered calls | 9. | GLD covered calls | 4. | UAMY covered calls | |
| 5. | IBIT covered calls | 10. | KWEB covered calls | 5. | ORCL covered calls | |
Want more examples? WAT Covered Calls | WB Covered Calls
Risk Disclosure: Trading options involves significant risk and is not suitable for all investors. The information provided on this website is for educational and informational purposes only and does not constitute financial, investment, tax, or legal advice. Nothing contained on this site is an offer to buy or sell, or a solicitation of an offer to buy or sell, any securities or financial instruments.
Covered Call Strategy Risks: While covered call writing is often considered a conservative options strategy, it is not without risk. By selling a covered call, you are limiting your potential upside profit from the underlying stock. You remain exposed to the full downside risk of owning the underlying stock. In the event of a significant decline in the stock price, the premium received may not be sufficient to offset your losses.
No Guarantee of Performance: Past performance is not indicative of future results. Any examples, calculations, or hypothetical scenarios presented on this site are for illustrative purposes only and do not guarantee future returns or outcomes. Market conditions, liquidity, and trading system failures can affect your ability to execute trades at desired prices.
You should consult with a qualified professional advisor and conduct your own due diligence before making any investment decisions. By using this website, you acknowledge that you are responsible for your own investment decisions and agree to release this site and its affiliates from any liability relating to your use of this information. See the OCC's Characteristics and Risks of Standardized Options for more info.
